| Cat# | TRA-038 |
| Specification | 100μg,1mg,10mg,100μg,0.5mg,5mg,100mg |
| Description | Preeclampsia (PE) is characterized by placental and maternal endothelial dysfunction, contributing to fetal growth restriction (FGR), placental abruption, preterm birth, and stillbirth. Soluble fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PLGF) are critical biomarkers for screening, predicting, diagnosing, and monitoring placental disorders. sFlt-1 (also known as sVEGFR-1) is an anti-angiogenic tyrosine kinase protein essential for vascular regulation in tissues such as the kidney, cornea, and uterus. |
| Applications | Suitable for detecting human sFlt-1, compatible with chemiluminescence, enzyme-linked immunosorbent assay, and immunochromatography methodologies. |
| Download Datasheet: |  |
